Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci-review of more than 25 biopsies from five patients

International Journal of Gynecological Cancer

Volumn 18, Issue 6, 2008, Pages 1305-1314

  Kamoi, S ^a,b   Ohaki, Y ^b   Mori, O ^b   Kurose, K ^a   Fukunaga, M ^c   Takeshita, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

High dose progestin therapy; Histologic changes of endometrial adenocarcinoma; Medroxyprogesterone acetate (MPA)

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CANCER MORPHOLOGY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CURETTAGE; CYTOPLASM; DRUG MEGADOSE; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MITOSIS INHIBITION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY;

ADENOCARCINOMA; ADULT; BIOPSY; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PROGESTINS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 55949096482     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01166.x     Document Type: Article

References (28)

1. Kim YB, Holschneider CH, Ghosh K et al. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997 79 : 320 7.
2. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997 90 : 434 40.
3. Jobo T, Imai M, Kawaguchi M et al. Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases. Eur J Gynecol Oncol 2000 21 : 119 22.
4. Sardi J, Anchezar Henry JP, Paniceres G et al. Primary hormonal treatment for early endometrial carcinoma. Eur J Gynecol Oncol 1998 19 : 565 8.
5. Ferrandina G, Zannoni GF, Gallotta V et al. Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol 2005 99 : 215 7.
6. Mitsuhita J, Toki T, Kato K et al. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol 2000 79 : 129 32.
7. Kaku T, Yoshikawa H, Tsuda H et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 2001 167 : 39 48.
8. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis the updated Sydney system. Am J Surg Pathol 1996 20 : 1161 81.
9. Silverberg SG, Kurman RJ. Endometrial carcinoma. In : Rosai J, ed. Tumors of the uterine corpus and gestational trophoblastic disease: atlas of tumor pathology facicle 3. Washington, DC : Armed Forces Institute of Pathology, 1992 1 89.
10. Kumar V, Abbas AK, Fausto N. Cellular adaptations, cell injury and cell death. In : Kumar V, Abbas AK, Fausto N, eds. Robbins & Cotran pathologic basis of disease, 7th edn. New York : Elsevier Saunders, 2004 3 46.
11. Anderson DG. The possible mechanism of action of progestins on endometrial adenocarcinoma. Am J Obstet Gynecol 1972 113 : 195 211.
12. Deligdisch L. Effects of hormone therapy on the endometrium. Mod Pathol 1993 6 : 94 106.
13. Kistner R. Histologic effects of progestins on hyperplasia and carcinoma in situ of endometrium. Cancer 1959 12 : 1106 22.
14. Richart RM, Ferenczy A. Endometrial morphologic response to hormonal environment. Gynecol Oncol 1974 2 : 180 97.
15. Quinn MA. Hormonal treatment of endometrial cancer. Hematol Oncol Clin North Am 1999 13 : 163 87.
16. Amezcua CA, Lu JJ, Felix JC et al. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol 2000 79 : 169 76.
17. Dahmoun M, Boman K, Cajander S et al. Intratumoral effect of medroxy-progesterone on proliferation, apoptosis, and sex steroid receptors in endometrioid endometrial adenocarcinoma. Gynecol Oncol 2004 92 : 116 26.
18. Saegusa M, Okayasu I. Progestin therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer 1998 83 : 111 21.
19. Miranda MC, Mazur MT. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia. Arch Pathol Lab Med 1995 119 : 458 60.
20. Zhang Z, Yuan XM, Li LH et al. Transdifferentiation in neoplastic development and its pathological implication. Histol Histopathol 2001 16 : 1249 62.
21. Tochigi N, Kishimoto T, Supriatna Y et al. Hepatoid carcinoma of the ovary: a report of three cases admixed with a common surface epithelial carcinoma. Int J Gynecol Pathol 2003 22 : 266 71.
22. Niwa K, Tagami K, Lian Z et al. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. Brit J Obstet Gynecol 2005 112 : 317 20.
23. Buckley CH, Fox H. The effect of therapeutic and contraceptive hormones on the endometrium. In : Neville AM, Walker F, Taylor CR, eds. Biopsy pathology of the endometrium, 2nd edn. Biopsy pathology series. London : Arnold, 2002 56 79.
24. Duska LR, Rueda BR. Primary hormonal therapy for endometrial carcinoma. In : Fuller AF, Seiden MV, Young RH, eds. Uterine cancer. Hamilton, ON : BC Decker, 2004 144 55.
25. Mazur MT, Kurman RJ, ed. Effects of hormones. In : Diagnosis of endometrial biopsies and curettings. New York : Springer-Verlag, 1995 109 30.
26. Ronnett BM, Zaino RJ, Ellenson LH et al. Endometrial carcinoma. Histological effects of treatment. In : Kurman RJ, ed. Blaustein's pathology of the female genital tract, 4th edn. New York : Springer-Verlag, 1994 457 8.
27. Zaino RJ. Endometrial carcinoma. In : Silververg SG, ed. Interpretation of endometrial biopsies and curettings. Biopsy interpretation series. New York : Lippincott-Raven, 1996 262 313.
28. Fujiwara H, Shibahara H, Usui R et al. Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma. Am J Reprod Immunol 2002 47 : 129 31.